Non-pathogenic tissue-resident CD8+ T cells uniquely accumulate in the brains of lupus-prone mice

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Morawski, Peter A ^a   Qi, Chen Feng ^a   Bolland, Silvia ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; LEUKOCYTE ANTIGEN; TOLL LIKE RECEPTOR 8; TRANSCRIPTION FACTOR;

ANIMAL; BLOOD BRAIN BARRIER; BRAIN; C57BL MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; CYTOLOGY; DISEASE MODEL; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE; PATHOLOGY; PHENOTYPE; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD; BLOOD-BRAIN BARRIER; BRAIN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL ADHESION MOLECULES; CENTRAL NERVOUS SYSTEM; CYTOKINES; DISEASE MODELS, ANIMAL; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PHENOTYPE; TOLL-LIKE RECEPTOR 8; TRANSCRIPTION FACTORS;

EID: 85009758613     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep40838     Document Type: Article

References (60)

1. Luijten, K. M. A. C., Tekstra, J., Bijlsma, J. W. J. & Bijl, M. The Systemic Lupus Erythematosus Responder Index (SRI); a new SLE disease activity assessment. Autoimmun Rev 11, 326-329 (2012).
2. Yee, C.-S. et al. The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients. Rheumatology (Oxford) 50, 982-988 (2011).
3. Brey, R. L. et al. Neuropsychiatric syndromes in lupus: Prevalence using standardized definitions. Neurology 58, 1214-1220 (2002).
4. Gulinello, M. & Putterman, C. The MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus. J. Biomed. Biotechnol. 2011, 207504 (2011).
5. Pomper, M. G., Miller, T. J., Stone, J. H., Tidmore, W. C. & Hellmann, D. B. CNS vasculitis in autoimmune disease: MR imaging findings and correlation with angiography. AJNR Am J Neuroradiol 20, 75-85 (1999).
6. Ramos-Casals, M. et al. Vasculitis in systemic lupus erythematosus: Prevalence and clinical characteristics in 670 patients. Medicine (Baltimore) 85, 95-104 (2006).
7. Faust, T. W. et al. Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms. Proceedings of the National Academy of Sciences 107, 18569-18574 (2010).
8. Fragoso-Loyo, H. et al. Serum and Cerebrospinal Fluid Autoantibodies in Patients with Neuropsychiatric Lupus Erythematosus. Implications for Diagnosis and Pathogenesis. PLoS ONE 3, e3347 (2008).
9. Kowal, C. et al. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc. Natl. Acad. Sci. USA 103, 19854-19859 (2006).
10. Lee, J. Y. et al. Neurotoxic autoantibodies mediate congenital cortical impairment of offspring in maternal lupus. Nature Medicine 15, 91-96 (2009).
11. Anderson, K. G. et al. Intravascular staining for discrimination of vascular and tissue leukocytes. Nature Protocols 9, 209-222 (2014).
12. Herz, J. et al. In vivo imaging of lymphocytes in the CNSreveals different behaviour of naïve T cells inhealth and autoimmunity. Journal of Neuroinflammation 8, 131 (2011).
13. Hickey, W. F., Hsu, B. L. & Kimura, H. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28, 254-260 (1991).
14. McGavern, D. B. & Kang, S. S. Illuminating viral infections in the nervous system. Nature Publishing Group 11, 318-329 (2011).
15. Goverman, J. Autoimmune T cell responses in the central nervous system. Nature Publishing Group 9, 393-407 (2009).
16. McDole, J., Johnson, A. J. & Pirko, I. The role of CD8+ T-cells in lesion formation and axonal dysfunction in multiple sclerosis. Neurol. Res. 28, 256-261 (2006).
17. Seksenyan, A. et al. Thymic involution, a co-morbidity factor in amyotrophic lateral sclerosis. J. Cell. Mol. Med. 14, 2470-2482 (2010).
18. James, W. G., Hutchinson, P., Bullard, D. C. & Hickey, M. J. Cerebral leucocyte infiltration in lupus-prone MRL/MpJ-fas lpr mice-roles of intercellular adhesion molecule-1 and P-selectin. Clin. Exp. Immunol. 144, 299-308 (2006).
19. McKinney, E. F. et al. A CD8+ T cell transcription signature predicts prognosis in autoimmune disease. Nature Medicine 16, 586-91, 1p following 591 (2010).
20. Park, C. O. & Kupper, T. S. The emerging role of resident memory T cells in protective immunity and inflammatory disease. Nature Medicine 21, 688-697 (2015).
21. Deane, J. A. et al. Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 27, 801-810 (2007).
22. Bolland, S. Genetic Modifiers of Systemic Lupus Erythematosus in FcgammaRIIB-/-Mice. Journal of Experimental Medicine 195, 1167-1174 (2002).
23. Galkina, E. et al. Preferential migration of effector CD8+ T cells into the interstitium of the normal lung. J. Clin. Invest. 115, 3473-3483 (2005).
24. Schenkel, J. M. & Masopust, D. Tissue-resident memory T cells. Immunity 41, 886-897 (2014).
25. Watanabe, R. et al. Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells. Sci Transl Med 7, 279ra39 (2015).
26. Bergsbaken, T. & Bevan, M. J. Proinflammatory microenvironments within the intestine regulate the differentiation of tissueresident CD8+ T cells responding to infection. Nature Immunology 16, 406-414 (2015).
27. Berlin, C. et al. Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74, 185-195 (1993).
28. Anderson, D. C. & Springer, T. A. Leukocyte adhesion deficiency: An inherited defect in the Mac-1, LFA-1, and p150,95 glycoproteins. Annu. Rev. Med. 38, 175-194 (1987).
29. Nong, Y. H., Remold-O'Donnell, E., LeBien, T. W. & Remold, H. G. A monoclonal antibody to sialophorin (CD43) induces homotypic adhesion and activation of human monocytes. J. Exp. Med. 170, 259-267 (1989).
30. Rosenstein, Y. et al. CD43, a molecule defective in Wiskott-Aldrich syndrome, binds ICAM-1. Nature 354, 233-235 (1991).
31. Feuerstein, G. Z., Liu, T. & Barone, F. C. Cytokines, inflammation, and brain injury: Role of tumor necrosis factor-Alpha. Cerebrovasc Brain Metab Rev 6, 341-360 (1994).
32. Graesser, D. et al. Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice. J. Clin. Invest. 109, 383-392 (2002).
33. Tada, Y. et al. Acceleration of the onset of collagen-induced arthritis by a deficiency of platelet endothelial cell adhesion molecule 1. Arthritis & Rheumatism 48, 3280-3290 (2003).
34. Wong, M.-X., Hayball, J. D., Hogarth, P. M. & Jackson, D. E. The inhibitory co-receptor, PECAM-1 provides a protective effect in suppression of collagen-induced arthritis. J. Clin. Immunol. 25, 19-28 (2005).
35. Zijlstra, M., Li, E., Sajjadi, F., Subramani, S. & Jaenisch, R. Germ-line transmission of a disrupted beta 2-microglobulin gene produced by homologous recombination in embryonic stem cells. Nature 342, 435-438 (1989).
36. McPhee, C. G. et al. MHC class I family proteins retard systemic lupus erythematosus autoimmunity and B cell lymphomagenesis. The Journal of Immunology 187, 4695-4704 (2011).
37. Charles, N., Hardwick, D., Daugas, E., Illei, G. G. & Rivera, J. Basophils and the T helper 2 environment can promote the development of lupus nephritis. Nature Medicine 16, 701-707 (2010).
38. Dema, B. et al. Immunoglobulin E plays an immunoregulatory role in lupus. Journal of Experimental Medicine 211, 2159-2168 (2014).
39. Walsh, E. R. et al. Dual signaling by innate and adaptive immune receptors is required for TLR7-induced B-cell-mediated autoimmunity. Proceedings of the National Academy of Sciences 109, 16276-16281 (2012).
40. Hanly, J. G., Walsh, N. M. & Sangalang, V. Brain pathology in systemic lupus erythematosus. J. Rheumatol. 19, 732-741 (1992).
41. Zameer, A. & Hoffman, S. A. B and T cells in the brains of autoimmune mice. J. Neuroimmunol. 146, 133-139 (2004).
42. Mrass, P. & Weninger, W. Immune cell migration as a means to control immune privilege: Lessons from the CNS and tumors. Immunol. Rev. 213, 195-212 (2006).
43. Irani, D. N. & Griffin, D. E. Regulation of lymphocyte homing into the brain during viral encephalitis at various stages of infection. J. Immunol. 156, 3850-3857 (1996).
44. Larochelle, C., Alvarez, J. I. & Prat, A. How do immune cells overcome the blood-brain barrier in multiple sclerosis FEBS Letters 585, 3770-3780 (2011).
45. Zameer, A. & Hoffman, S. A. Increased ICAM-1 and VCAM-1 expression in the brains of autoimmune mice. J. Neuroimmunol. 142, 67-74 (2003).
46. Brey, R. L., Amato, A. A., Kagan-Hallet, K., Rhine, C. B. & Stallworth, C. L. Anti-intercellular adhesion molecule-1 (ICAM-1) antibody treatment prevents central and peripheral nervous system disease in autoimmune-prone mice. Lupus 6, 645-651 (1997).
47. Meekins, J. W., McLaughlin, P. J., West, D. C., McFadyen, I. R. & Johnson, P. M. Endothelial cell activation by tumour necrosis factoralpha (TNF-Alpha) and the development of pre-eclampsia. Clin. Exp. Immunol. 98, 110-114 (1994).
48. Xia, P. et al. Tumor necrosis factor-Alpha induces adhesion molecule expression through the sphingosine kinase pathway. Proc. Natl. Acad. Sci. USA. 95, 14196-14201 (1998).
49. Jiang, X. et al. Skin infection generates non-migratory memory CD8+ T(RM) cells providing global skin immunity. Nature 483, 227-231 (2012).
50. Gebhardt, T. et al. Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus. Nature Immunology 10, 524-530 (2009).
51. Clark, R. A. et al. The vast majority of CLA+ T cells are resident in normal skin. J. Immunol. 176, 4431-4439 (2006).
52. Sasaki, K. et al. Relapsing-remitting central nervous system autoimmunity mediated by GFAP-specific CD8 T cells. The Journal of Immunology 192, 3029-3042 (2014).
53. Smolders, J. et al. Characteristics of differentiated CD8(+ ) and CD4 (+ ) T cells present in the human brain. Acta Neuropathol. 126, 525-535 (2013).
54. Dinesh, R. K., Skaggs, B. J., La Cava, A., Hahn, B. H. & Singh, R. P. CD8+ Tregs in lupus, autoimmunity, and beyond. Autoimmun Rev 9, 560-568 (2010).
55. Li, S. et al. A naturally occurring CD8(+ )CD122(+ ) T-cell subset as a memory-like Treg family. Cell. Mol. Immunol. 11, 326-331 (2014).
56. Voynova, E., Qi, C.-F., Scott, B. & Bolland, S. Cutting Edge: Induction of Inflammatory Disease by Adoptive Transfer of an Atypical NK Cell Subset. The Journal of Immunology 195, 806-809 (2015).
57. Voynova, E. N., Skinner, J. & Bolland, S. Expansion of an atypical NK cell subset in mouse models of systemic lupus erythematosus. The Journal of Immunology 194, 1503-1513 (2015).
58. Poulsen, L. K. & Hummelshoj, L. Triggers of IgE class switching and allergy development. Ann. Med. 39, 440-456 (2007).
59. van der Kleij, H. et al. Evidence for neuronal expression of functional Fc (epsilon and gamma) receptors. J. Allergy Clin. Immunol. 125, 757-760 (2010).
60. Fletcher, A. L. et al. Reproducible isolation of lymph node stromal cells reveals site-dependent differences in fibroblastic reticular cells. Front Immunol 2, 35 (2011).